Literature DB >> 18562881

Diffusion-weighted magnetic resonance is better than polymerase chain reaction for early diagnosis of herpes simplex encephalitis: a case report.

Başak Nur Akyldz1, Hakan Gümüş, Sefer Kumandaş, Abdülhakim Coşkun, Musa Karakukuçu, Ali Yklmaz.   

Abstract

Herpes simplex virus infection of the central nervous system is still a significant cause of morbidity and often mortality. Early diagnosis is critical because treatment with the antiviral drug acyclovir dramatically decreases morbidity and mortality in children. The use of polymerase chain reaction techniques is a diagnostic procedure in herpes simplex virus infection, but negative polymerase chain reaction test results of cerebrospinal fluid herpes simplex virus can occur within the first 72 hours of illness, with subsequent test results becoming positive as in this case. Therefore, diffusion-weighted magnetic resonance may play a major role as a first and early diagnostic step.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18562881     DOI: 10.1097/PEC.0b013e318177a712

Source DB:  PubMed          Journal:  Pediatr Emerg Care        ISSN: 0749-5161            Impact factor:   1.454


  4 in total

Review 1.  "Dazed and diffused": making sense of diffusion abnormalities in neurologic pathologies.

Authors:  K M O'Connor; G Barest; T Moritani; O Sakai; A Mian
Journal:  Br J Radiol       Date:  2013-10-28       Impact factor: 3.039

2.  DWI and FLAIR imaging in herpes simplex encephalitis: a comparative and topographical analysis.

Authors:  Dimitri Renard; Elodie Nerrant; Catherine Lechiche
Journal:  J Neurol       Date:  2015-06-20       Impact factor: 4.849

3.  A study on viral CNS inflammation beyond herpes encephalitis.

Authors:  Berit Jordan; Sabrina Kösling; Alexander Emmer; Antje Koch; Tobias Müller; Malte Kornhuber
Journal:  J Neurovirol       Date:  2016-05-12       Impact factor: 3.739

Review 4.  Acute encephalitis.

Authors:  Dennis W Simon; Yong Sing Da Silva; Giulio Zuccoli; Robert S B Clark
Journal:  Crit Care Clin       Date:  2013-02-11       Impact factor: 3.598

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.